Literature DB >> 26104359

Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response.

Diana Karpman, Anne-Lie Ståhl.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) is a highly pathogenic bacterial strain capable of causing watery or bloody diarrhea, the latter termed hemorrhagic colitis, and hemolytic-uremic syndrome (HUS). HUS is defined as the simultaneous development of non-immune hemolytic anemia, thrombocytopenia, and acute renal failure. The mechanism by which EHEC bacteria colonize and cause severe colitis, followed by renal failure with activated blood cells, as well as neurological symptoms, involves the interaction of bacterial virulence factors and specific pathogen-associated molecular patterns with host cells as well as the host response. The innate immune host response comprises the release of antimicrobial peptides as well as cytokines and chemokines in addition to activation and/or injury to leukocytes, platelets, and erythrocytes and activation of the complement system. Some of the bacterial interactions with the host may be protective in nature, but, when excessive, contribute to extensive tissue injury, inflammation, and thrombosis, effects that may worsen the clinical outcome of EHEC infection. This article describes aspects of the host response occurring during EHEC infection and their effects on specific organs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26104359     DOI: 10.1128/microbiolspec.EHEC-0009-2013

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  18 in total

Review 1.  Overview and Historical Perspectives.

Authors:  James B Kaper; Alison D O'Brien
Journal:  Microbiol Spectr       Date:  2014-12

Review 2.  Enterohemorrhagic Escherichia coli and a Fresh View on Shiga Toxin-Binding Glycosphingolipids of Primary Human Kidney and Colon Epithelial Cells and Their Toxin Susceptibility.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

3.  Characterization of Atypical Shiga Toxin Gene Sequences and Description of Stx2j, a New Subtype.

Authors:  Alexander Gill; Forest Dussault; Tanis McMahon; Nicholas Petronella; Xiong Wang; Elizabeth Cebelinski; Flemming Scheutz; Kelly Weedmark; Burton Blais; Catherine Carrillo
Journal:  J Clin Microbiol       Date:  2022-03-16       Impact factor: 11.677

4.  Changes in Gene Transcription Induced by Hydrogen Peroxide Treatment of Verotoxin-Producing Escherichia coli O157:H7 and Non-O157 Serotypes on Romaine Lettuce.

Authors:  Gui-Ying Mei; Joshua Tang; Susan Bach; Magdalena Kostrzynska
Journal:  Front Microbiol       Date:  2017-03-21       Impact factor: 5.640

5.  Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; David H Francis; Mizuho Tamura; David B Marx; Kristina Santiago-Mateo; Mojun Zhao
Journal:  Toxins (Basel)       Date:  2017-01-26       Impact factor: 4.546

6.  LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice.

Authors:  Shuo Niu; John Paluszynski; Zhen Bian; Lei Shi; Koby Kidder; Yuan Liu
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

7.  Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli.

Authors:  Colin W Russell; Brittany A Fleming; Courtney A Jost; Alexander Tran; Alan T Stenquist; Morgan A Wambaugh; Mary P Bronner; Matthew A Mulvey
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

8.  The Escherichia coli O157:H7 carbon starvation-inducible lipoprotein Slp contributes to initial adherence in vitro via the human polymeric immunoglobulin receptor.

Authors:  Christine Fedorchuk; Indira T Kudva; Subhashinie Kariyawasam
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

Review 9.  Microvesicle Involvement in Shiga Toxin-Associated Infection.

Authors:  Annie Villysson; Ashmita Tontanahal; Diana Karpman
Journal:  Toxins (Basel)       Date:  2017-11-19       Impact factor: 4.546

Review 10.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.